search

Amphastar P (AMPH)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Amphastar Pharmaceuticals, Inc. $AMPH Stock: Bridge City Capital LLC Boosts Position
Nov 2, 2026

Amphastar Pharmaceuticals, Inc. $AMPH Stock: Bridge City Capital LLC Boosts Position

Bridge City Capital LLC increased its stake in Amphastar Pharmaceuticals (NASDAQ:AMPH) by 13.3% in the third quarter, bringing its total holdings to 383,901 shares valued at $9.9 million. This makes Amphastar Pharmaceuticals its sixth-largest position, representing 2.1% of its investment portfolio. Despite the company reporting stronger-than-expected quarterly earnings and revenue, analyst sentiment remains cautious with an average "Reduce" rating and a price target of $22.50, below its current trading price of $27.72.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral